. 2013 Jun 24;33(4):233–241. doi: 10.3343/alm.2013.33.4.233

Table 3.

Effects of total prostate-specific antigen (tPSA) screening on mortality and diagnosis

graphic file with name alm-33-233-i003.jpg

^*ERSPC (50-74 yr) 2009 [4], Göteborg (60-64 yr) 2010 [17], PLCO (55-74 yr) 2009 [3], Quebec (45-80 yr) 2004 [18]; ^†ERSPC (50-74 yr) 2009 [4], Göteborg (60-64 yr) 2010 [17], PLCO (55-74 yr) 2009 [3]; ^‡ERSPC (50-74 yr) 2009 [4], French ERSPC (55-69 yr) 2009 [19], Göteborg (60-64 yr) 2010 [17], PLCO (55-74 yr) 2009 [3]; ^§ERSPC (50-74 yr) 2009 [4], French ERSPC (55-69 yr) 2009 [19], PLCO (55-74 yr) 2009 [3].

Abbreviation: Pca, Prostate cancer.